{
    "title": "Individual feed for https://stocktwits.com/sitemap/rss_feed.xml",
    "link": "https://stocktwits.com/sitemap/rss_feed.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-12-24T11:01:06.511804",
    "items": [
        {
            "title": "Micron Stock Hits Record High Before Christmas — Futurum Equities Says Market Is Repricing Firm Toward Durable AI Margins",
            "link": "https://stocktwits.com/news-articles/markets/equity/micron-stock-hits-record-high-before-christmas-futurum-equities-says-market-repricing-toward-durable-ai-margins/cLeszelREvS",
            "description": "The record high comes as investors reassess Micron’s positioning in the AI-driven memory market.",
            "pubDate": "2025-12-24T15:57:16",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        },
        {
            "title": "Netflix Pushes Back On TRC Capital’s Mini-Tender Bid At Below-Market Price",
            "link": "https://stocktwits.com/news-articles/markets/equity/netflix-pushes-back-on-trc-capital-mini-tender-bid-at-below-market-price/cLesy0MREv0",
            "description": "TRC is looking to purchase 1.25 million shares of Netflix common stock at a price of $91 per share in cash.",
            "pubDate": "2025-12-24T15:28:18",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        },
        {
            "title": "Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year?",
            "link": "https://stocktwits.com/news-articles/markets/equity/psychedelics-break-out-under-rfk-jr-reset-mnmd-or-cmps-2025-winner/cLesx14REvi",
            "description": "Regulatory thaw, political backing, and late-stage data are propelling psychedelic drugmakers into the biotech spotlight — with Compass Pathways and M...",
            "pubDate": "2025-12-24T14:52:15",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        },
        {
            "title": "Omeros Stock Jumps Premarket After FDA Approves First Drug For Rare Transplant Complication — Retail Sees Big Upside",
            "link": "https://stocktwits.com/news-articles/markets/equity/omeros-stock-jumps-premarket-after-fda-approves-first-drug-for-rare-transplant-complication/cLesxhYREvL",
            "description": "The drug was approved for use in adults and children aged two years and older.",
            "pubDate": "2025-12-24T14:49:37",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png"
        },
        {
            "title": "Why Did AGIO Stock Surge 14% Today?",
            "link": "https://stocktwits.com/news-articles/markets/equity/why-did-agio-stock-surge-14-today/cLesxI9REvh",
            "description": "Agios Pharmaceuticals announced that the FDA approved its oral therapy for anemia in adults with alpha- or beta-thalassemia.",
            "pubDate": "2025-12-24T14:41:05",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png"
        }
    ]
}